Company Filing History:
Years Active: 2018-2022
Title: Innovations and Contributions of Inventor Kaiwei Liang
Introduction
Kaiwei Liang is a prominent inventor based in Chicago, IL (US). He has made significant contributions to the field of cancer therapy through his innovative research and development of small molecules. With a total of 3 patents, his work focuses on disrupting complex biological processes that contribute to cancer progression.
Latest Patents
One of his latest patents involves small molecules designed to disrupt the super elongation complex and inhibit transcription elongation for cancer therapy. This patent discloses compounds that can inhibit transcription by RNA Polymerase II (Pol II), particularly targeting the Super Elongation Complex (SEC). These compounds are intended for use in pharmaceutical compositions and methods for treating diseases associated with high levels of SEC-dependent gene expression, such as various cancers.
Another significant patent addresses therapeutic targeting of interleukin-1 receptor-associated kinase 4 (IRAK4) in cancers characterized by rearrangements in the mixed lineage leukemia gene (MLL-r). This patent outlines methods for treating cancers associated with MLL-r, including MLL-r leukemia. The methods typically involve administering therapeutic agents that inhibit the biological activity of members of the interleukin-1 signaling pathway, specifically targeting IRAK4.
Career Highlights
Kaiwei Liang is affiliated with Northwestern University, where he continues to advance his research in cancer therapy. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from aggressive forms of cancer.
Collaborations
He has collaborated with notable colleagues, including Ali Shilatifard and Edwin Richard Smith, to further enhance the impact of his research. Their combined expertise contributes to the development of innovative therapeutic strategies.
Conclusion
Kaiwei Liang's contributions to cancer therapy through his innovative patents highlight the importance of research in developing effective treatments. His work continues to inspire advancements in the field of oncology.